Do popular weight loss drugs make colonoscopies riskier?

NCT ID NCT07127354

First seen Jan 05, 2026 · Last updated Apr 18, 2026 · Updated 15 times

Summary

This study aims to understand if continuing GLP-1 or GIP agonist medications (used for diabetes and weight loss) affects how well patients prepare for a colonoscopy. Researchers will compare people who take their usual dose before the procedure to those who skip it, looking at bowel prep quality and safety. The goal is to gather evidence to help doctors give better instructions to patients taking these common medications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLP-1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cleveland Clinic

    RECRUITING

    Cleveland, Florida, 44195, United States

  • Cleveland Clinic

    RECRUITING

    Cleveland, Florida, 44195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Cleveland Clinic Weston

    RECRUITING

    Weston, Florida, 33331, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.